VCEL

#1768
Vericel Corporation - Common Stock
33.3 3 USD
-2.66%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
33.33
33.33
Range Annuel
0.34
43.00
Changement quotidien
-2.66%
Changement Mensuel
-0.30%
Evolution sur 6 mois
-16.21%
Changement Annuel
-8.31%
Clôture Précédente
34.2 4
Open
33.3 3
Low
33.3 3
High
33.3 3
Volume
114
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 1.7 B
  • Employee 398
  • Founded 1989
  • CEO Nick Colangelo
  • Website www.vcel.com
  • Headquarter Michigan, United States
  • FIGI BBG000BDCM24
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
112.53
ratio cours/chiffre d'affaires
6.8

Vericel Corporation - Common Stock

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

Nouvelles